# Profermin® in Active Ulcerative Colitis

> **NCT01245465** · PHASE1,PHASE2 · COMPLETED · sponsor: **Nordisk Rebalance A/S** · enrollment: 39 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **OTHER:** Profermin

## Key facts

- **NCT ID:** NCT01245465
- **Lead sponsor:** Nordisk Rebalance A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2010-11-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01245465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01245465, "Profermin® in Active Ulcerative Colitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01245465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*